Company Information

Company Daiichi Sankyo Co. Ltd.
Pharmaceuticals & Biotechnology
Publicly Listed
Global Compact Status:
Participant Since
12 April 2012
Letter of Commitment

Financial Information

Affiliated Subsidiaries

Country Company Name
Brazil Daiichi Sankyo Brasil Farmaceutica

Communication On Progress

Published On Title Level
2022-12-23 Daiichi Sankyo Group Value Report 2022 Advanced
2021-12-25 Communication on Progress Advanced
2020-12-25 Daiichi Sankyo Group Value Report 2020 Advanced
2019-12-26 Daiichi Sankyo Group Value Report 2019 Advanced
2018-12-26 Daiichi Sankyo Group Value Report 2018 Advanced
2017-12-26 Communication on Progress Advanced
2016-12-26 Communication on Progress Advanced
2015-12-24 Communication on Progress Advanced
2014-12-25 Value Report 2014 Advanced
2013-12-26 Value Report 2013 Advanced
2013-02-25 Communication on Progress Advanced

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.